| Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
8,898 | 9,624 | 7,845 | 8,052 | 6,064 | 10,228 | 3,983 | 3,542 | 2,750 |
General and administrative | ||||||||
9,663 | 3,453 | 3,019 | 3,324 | 2,776 | 3,569 | 2,025 | 677 | 730 |
Total operating expenses | ||||||||
18,561 | 13,077 | 10,864 | 11,376 | 8,840 | - | 6,008 | 4,219 | - |
Other income (expense): | ||||||||
Interest and other income | ||||||||
1,107 | 975 | 798 | 722 | 367 | - | 55 | 2 | - |
Other income (expense), net | ||||||||
1,101 | 3,527 | 4,127 | 2,224 | -5,885 | - | -2,258 | -4 | - |
Total other income (expense), net | ||||||||
2,208 | 4,502 | 4,925 | 2,946 | -5,518 | 51 | -2,203 | -2 | 8 |
Loss before provision for income taxes | ||||||||
-16,353 | -8,575 | -5,939 | -8,430 | -14,358 | -13,746 | -8,211 | -4,221 | -3,472 |
Provision for income taxes | ||||||||
39 | -189 | 83 | -334 | 0 | 37 | 0 | - | - |
Net loss | ||||||||
-16,392 | -8,386 | -6,022 | -8,096 | -14,358 | -13,783 | -8,211 | -4,221 | -3,472 |
Other comprehensive income (loss): | ||||||||
Foreign currency translation adjustment | ||||||||
0 | -3,765 | -2,711 | -6,615 | 6,346 | - | 1,848 | 1,579 | - |
Change in net unrealized holding gains (losses) on available for sale securities | ||||||||
-1,258 | - | -1,618 | 3,934 | - | - | - | - | - |
Total other comprehensive loss | ||||||||
-17,650 | -12,386 | -10,351 | -10,777 | -8,012 | - | -6,363 | -2,642 | - |
Basic and diluted net loss per ordinary share | ||||||||
-0.50 | -0.26 | -0.21 | -0.29 | -0.52 | -0.50 | -0.38 | -0.18 | -0.30 |
Weighted average basic and diluted ordinary shares | ||||||||
32,944 | 32 | 28,139 | 28,053 | 27,862 | 27 | 21,514 | 23,688 | 11 |